Stocks and securities in focus
| Security | Change (%) | 1w ▲ | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mirati Therapeutics Inc. | -0.040% | - | - | - | - | - | - |
| Applied Therapeutics Inc | -1.840% | - | - | - | - | - | - |
| Faron Pharmaceuticals Oy | -2.880% | - | - | - | - | - | - |
| Moleculin Biotech Inc | 1.530% | - | - | - | - | - | - |
| Apellis Pharmaceuticals | -0.970% | - | - | - | - | - | - |
| Minerva Neurosciences Inc. | -1.720% | - | - | - | - | - | - |
| Mesoblast Ltd ADR | -3.160% | - | - | - | - | - | - |
| Amneal Pharmaceuticals Inc | 0.960% | - | - | - | - | - | - |
| Enlivex Therapeutics Ltd. | -21.970% | -52.210% | -53.243% | -34.470% | -22.768% | -80.778% | - |
| Gritstone Oncology Inc | -1.230% | -25.936% | -68.161% | -74.304% | -62.729% | -90.610% | - |
| Inotiv Inc. | -1.790% | -20.896% | -30.263% | 25.592% | 61.585% | - | - |
| Adaptimmune Therapeutics PLC ADR | -9.090% | -20.000% | -26.471% | -20.000% | 60.000% | -76.190% | - |
| Fibrogen Inc. | 1.140% | -18.100% | -36.347% | -93.137% | 42.849% | -92.372% | - |
| Fate Therapeutics Inc. | -5.420% | -13.850% | -22.566% | -5.278% | 49.381% | -92.465% | - |
| Trupanion Inc. | -0.960% | -12.694% | -16.305% | -44.941% | -24.218% | -68.443% | - |
| Adocia | -0.110% | -12.475% | 1.260% | 197.643% | -24.830% | -10.526% | -39.202% |
| Emergent Biosolutions Inc. | -0.770% | -12.424% | -17.854% | -82.672% | -16.158% | -97.001% | -96.008% |
| Oramed Pharmaceuticals | 3.960% | -10.898% | -17.794% | 11.805% | 7.420% | -68.990% | -38.250% |
| Coherus Bioscien. | -1.730% | -10.401% | 2.519% | -71.793% | -31.711% | -82.555% | -84.194% |
| Atara Biotherapeutics Inc. | -9.300% | -10.159% | 14.360% | -73.227% | 28.465% | -94.365% | - |
| Viking Therapeutics Inc | -1.520% | -9.820% | 9.185% | 269.285% | 260.309% | 1177.631% | - |
| Bluebird Bio Inc. | 2.110% | -9.250% | -25.577% | -65.721% | -21.845% | -96.075% | - |
| Personalis Inc | 5.820% | -9.049% | -19.044% | -57.461% | -42.981% | -93.921% | - |
| Cardiff Oncology Inc. | 1.210% | -8.656% | 9.251% | 244.444% | 276.900% | -32.517% | 41.714% |
| Medigene AG | -1.510% | -8.525% | 22.154% | 9.669% | 24.843% | -48.642% | -77.908% |
| Evolus Inc | -2.630% | -8.197% | -12.500% | 43.590% | 19.786% | 18.519% | - |
| Iovance Biotherapeutics Inc. | -6.080% | -7.063% | -12.343% | 117.861% | 43.251% | -55.999% | - |
| SELLAS Life Sciences Group Inc | -2.690% | -7.057% | 20.194% | -14.973% | 26.974% | -81.242% | -99.663% |
| Akebia Therapeutics Inc. | -2.180% | -5.878% | -14.961% | 127.951% | 12.031% | -48.711% | - |
| Ardelyx Inc. | -3.190% | -5.210% | -13.459% | 49.277% | 10.796% | -11.669% | - |